• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2020 October 27

Post Archive by Day

View Post

Quality of Life Varies With Breast Cancer Surgery Type

In HealthDay News
by Healthday
October 27, 2020

Body image, sexual health, anxiety worse after bilateral mastectomy

View Post

Vosoritide Aids Bone Growth in Children With Dwarfism

In HealthDay News
by Healthday
October 27, 2020

Compared with placebo, vosoritide increased growth velocity to near-normal annual rate

View Post

Infectious Disease Least Severe in School-Aged Children

In HealthDay News
by Healthday
October 27, 2020

For many infections, even young adults have more severe infection than children, except for dengue

View Post

Air Pollution Tied to Neurological Disorders in Seniors

In HealthDay News
by Healthday
October 27, 2020

Higher fine particulate matter tied to higher risk for Parkinson disease, Alzheimer disease

View Post

Incident CVD Up With Sugary, Artificially Sweetened Drinks

In HealthDay News
by Healthday
October 27, 2020

Risks for first incident CVD increased for higher consumers of sugary drinks, ASBs versus nonconsumers

View Post

Many U.S. Young Adults Not Aware of Stroke Symptoms

In HealthDay News
by Healthday
October 27, 2020

28.9 percent of young adults not aware of all five stroke symptoms; 2.7 percent not aware of any

View Post

Most Couples Concordant for Cardiovascular Risk

In HealthDay News
by Healthday
October 27, 2020

In 79 percent of couples, both members are in nonideal category for cardiovascular health score

View Post

ACA Protects Coverage for Pediatric Cancer Patients

In HealthDay News
by Healthday
October 27, 2020

Dependent coverage provision cuts risk for insurance loss by 15 percent

Quality Assurance and Characterisation of NB-UVB Devices for use at home – Lessons from the Hi-Light Vitiligo Trial.

In Dermatology
by ClinOwl
October 27, 2020

Hand-held narrowband UVB (NB-UVB) devices are available for the treatment of various skin conditions, but their optical radiation omissions are often not thoroughly characterised. Following a pilot study1 that identified …

Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one-year observational cohort study of the first 100 patients treated.

In Dermatology
by ClinOwl
October 27, 2020

Dupilumab (Dupixent®) is the first biologic drug licensed for treatment of adults with atopic dermatitis (AD). Data regarding its long-term real-world effectiveness and tolerability are limited. We report comprehensive outcome …

  • Page 1 of 2
  • 1
  • 2
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

October 2020
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep   Nov »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer